Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law Blog
DECEMBER 4, 2023
The government asserted additional allegations that are outside our scope. 12, 2012). “[W]hen the circumstances surrounding the presentation of a prescription would give rise to suspicion in a ‘reasonable professional,’ there is a duty to question the prescription.” Zarzamora Press Release. Consent Agreement and Final Judgment 2-3.
139 
Let's personalize your content